INTRODUCTION
vWF (von Willebrand factor) is a very large multimeric plasma glycoprotein expressed by vascular endothelial cells and megakaryocytes. vWF is a key component for maintenance of normal haemostasis, mediating two essential functions. First, it supports platelet adhesion to damaged surfaces at sites of vascular injury by interacting with both the exposed sub-endothelial matrix proteins and the platelet glycoprotein complexes GpIbα and GpIIbIIIa [1] . Secondly, it acts as the carrier molecule for the pro-coagulant Factor VIII, increasing its half-life in blood from 2 to 12 h in humans and protecting it from activation by Factor Xa and inactivation by protein C [2, 3] . During its biosynthesis vWF undergoes extensive post-translational modification, including pro-peptide cleavage, multimerization and glycosylation, leading to a wide range of very large and structurally complex disulfidelinked multimeric structures of 0.5×10 6 to over 2×10 7 Da. The mature vWF monomer macrostructure is conventionally organized into four groups of homologous repeating domains, named A, B, C and D, joined together by unstructured linkers. A number of functional domains have been characterized along the 2813 amino acid vWF sequence, being involved either in its intrinsic properties {dimerization, multimerization and cleavage by the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs)-13 metalloprotease [4] } or in its interaction with partner proteins such as Factor VIII [5] , collagens [6, 7] , platelet GpIbα and GpIIbIIIa [8, 9] , P-selectin [10] or heparin [11] .
The initial determination of the vWF amino acid sequence by Titani et al. [12] highlighted the presence of twelve ). All but one of these sites (Asn 2635 ) was reported to be occupied with N-glycans. An additional rare sequon, N-X-C (Asn 1147 ), was also found to be glycosylated. Early studies of the vWF N-glycan population led to the characterization of approximately 25 N-glycan structures [13] [14] [15] . Complex type bi-antennary structures were shown to constitute approximately 80 % of the glycans identified, accompanied by tri-and tetra-antennary analogues as well as a minority of high mannose type N-glycans. Some structural features, such as core fucosylation, antennae sialylation and the presence of lactosaminic elongations and of bisecting GlcNAc residues, characterized the overall population. Interestingly, approximately 13 % of the vWF N-glycans were shown to carry ABH blood group epitopes, an uncommon feature for a secreted glycoprotein.
N-glycosylation consensus sequons N-X-S/T (amino acids
Most of the vWF N-glycosylation consensus sequons are located in the vicinity of, or within, a functional site, and it is therefore not surprising that vWF glycan content affects its properties and functions, such as secretion and dimerization [16, 17] , multimerization [18] and half-life in blood [19] . One of the most striking effects is the correlation between the ABO blood group and vWF plasma level. Significant differences between all ABO groups have been demonstrated by many studies, demonstrating the highest levels for blood group AB individuals, followed by group A and group B, and lowest levels for group O individuals, i.e. AB > A B > O [20, 21] . The mechanism by which ABH antigens affect the plasma level of vWF remains unclear, although most evidence points to an effect on vWF clearance. ABH antigens also alter vWF susceptibility to proteolysis by ADAMTS-13, a specific protease regulating vWF multimeric size, with a cleavage rate in the rank order O > B A > AB [22] . vWF sialylation has also been shown to specifically enhance susceptibility to ADAMTS-13 proteolysis [23] , while protecting it against cleavage by other serine and cysteine proteases such as plasmin, trypsin and chymotrypsin [24] . Interestingly, a recent study by McGrath et al. [23] additionally demonstrated that desialylation abolishes the ABH effect on the ADAMTS-13 cleavage rate, i.e. asialo-O-vWF and asialo-AB-vWF are cleaved at identical rates by ADAMTS-13.
Although substantial evidence shows a significant influence of the vWF glycan content on its biology and functions, most of the underlying molecular mechanisms remain poorly understood, in part because the knowledge of its glycans is still vastly incomplete. Only a portion of the vWF glycan repertoire has been rigorously defined, and almost nothing is known regarding sialylation and potential further modifications. In addition, until now, nothing has been known concerning the specificity of glycosylation at each of the consensus sites. In the present paper, we describe our structural definition of the vWF N-glycan repertoire using advanced mass spectrometric techniques. We report structural features which have not been addressed previously, such as sulfation, sialylation status and the presence of terminal nonbisecting GlcNAc residues. Importantly, we show that ABH blood group-substituted glycans are distributed throughout the vWF molecule.
MATERIALS AND METHODS vWF
Plasma-derived vWF was purified from Haemate P (ZLB) using a combination of gel filtration and heparin-Sepharose affinity chromatography. Briefly, Haemate P was gel-filtered through a HiPrep Sephacryl S-400 HR gel-filtration column (GE Healthcare) using 20 mM Tris/HCl and 100 mM NaCl (pH 7.4). vWFcontaining fractions were pooled and passed over an SK-16 chromatography column packed with 30 ml of heparin-Sepharose 6 fast flow (GE Healthcare). The column was eluted with 20 mM Tris/HCl and 300 mM NaCl (pH 7.4) and the resulting fraction was dialysed into 50 mM ammonium bicarbonate (pH 7.4) before freeze-drying.
General chemicals and reagents
Ammonium hydrogen carbonate, sodium chloride, IAA (iodoacetic acid), DTT (dithiothreitol), α-cyano-4-hydroxycinnamic acid and hexanes were purchased from Sigma-Aldrich. Glacial acetic acid, acetonitrile, ammonia, chloroform, DMSO, methanol, propan-1-ol, sodium hydroxide pellets and TFA (trifluoroacetic acid) were from Romil. Gentisic acid (2,5 re-dihydroxybenzoic acid) was from Fluka. Methyl iodide was obtained from Alpha Aesar. Snakeskin ® dialysis tubing (cut-off 7 kDa) was from Pierce. Tris(hydroxymethyl)aminomethane was from Fisher. DABP (3,4-diaminobenzophenone) was from Acros Organics. Argon and nitrogen gases were supplied by BOC. All aqueous solutions were prepared using distilled/deionized (Milli-Q) water.
Carboxymethylation
Freeze-dried vWF aliquots (typically 100 μg) were dissolved in 200 μl of 2 mg/ml DTT in degassed 0.6 M Tris (pH 8.5) buffer and reduction was carried out by incubation for 60 min at 37
• C. The same volume of 60 mg/ml IAA in degassed 0.6 M Tris (pH 8.5) buffer was then added and carboxymethylation was performed by incubation for 2 h at room temperature (20 • C). The reaction was terminated by dialysing samples against 50 mM ammonium bicarbonate (pH 7.4) buffer for 36 h at 4
• C. After dialysis, the vWF samples were freeze-dried.
Tryptic and PNGase F (peptide N-glycosidase F) digestions
For glycomics analyses, reduced-carboxymethylated vWF was incubated with Tos-Phe-CH 2 Cl ('TPCK'; tosylphenylalanylchloromethane)-treated bovine pancreas trypsin (EC 3.4.21.4; Sigma) at a 1:50 (w/w) ratio in 50 mM ammonium bicarbonate (pH 8.4) buffer, for 12 h at 37
• C. For glycoproteomic analyses, reduced-carboxymethylated vWF was digested using Sequencing Grade Modified Trypsin (Promega) at a 1:50 (w/w) ratio in a 50 mM ammonium bicarbonate (pH 8.4) buffer, for 2-14 h at 37
• C. The digestion was terminated by the addition of one drop of acetic acid and the sample was immediately purified on a reverse-phase C 18 Sep-Pak cartridge (Waters) using the propan-1-ol/5 % acetic acid method. The C 18 cartridge was conditioned successively with methanol, 5 % acetic acid, propan-1-ol and 5 % acetic acid. The tryptic digest was loaded on to the cartridge and washed with 20 ml of 5 % acetic acid. vWF peptides and glycopeptides were eluted sequentially with each 20 %, 40 % and 100 % (v/v) propan-1-ol in water. The 20 % and 40 % propan-1-ol fractions were pooled and freeze-dried. For the PNGase F digestion, the vWF tryptic digest was suspended in 50 mM ammonium bicarbonate (pH 8.4) and digested with 3 units of the enzyme for 24 h at 37
• C. The released N-glycans were extracted and purified from the sample using a Sep-Pak C 18 cartridge with the propan-1-ol/5 % acetic acid method as above, the N-glycans being eluted using 5 ml of 5 % acetic acid. The volume of this fraction was reduced on a Savant Speed-Vac and purified N-glycans were finally freeze-dried.
Digestion by endo-β-galactosidase
Polylactosaminic elongations carried by vWF N-glycans were digested using a recombinant endo-β-galactosidase from Escherichia freundii (EC 3.2.1.103, Seikagaku). The sample was dissolved in 50 mM ammonium acetate (pH 5.5) buffer. Then, 25 munits of the endo-β-galactosidase were added and the sample was incubated for 18 h at 37
• C. Another aliquot of the enzyme was added, and the sample was again incubated for 18 h at 37
• C. Glycans were purified using a Sep-Pak C 18 cartridge with the propan-1-ol/5 % acetic acid method before freeze-drying.
Galactosylation with β 1,4 -galactosyltransferase
Purified N-glycans were dissolved in 100 μl of a 50 mM Mops and 20 mM MnCl 2 (pH 7.4) buffer containing 1 mg/ml UDPgalactose. Then, 1 m-unit of β 1,4 -galactosyltransferase from bovine milk (EC 2.4.1.90, Merck) was added and the sample was incubated for 24 h at 37
• C. Another aliquot of the enzyme solution was then added and the sample was again incubated for 24 h at 37
• C. After the reaction, glycans were purified using a Sep-Pak C 18 cartridge with the propan-1-ol/5 % acetic acid method before freeze-drying.
Digestion by neuraminidase
Desialylation of released glycans or glycopeptides was achieved using a recombinant neuraminidase from Vibrio cholerae (EC 3.2.1.18, Sigma). The sample was dissolved in 50 mM ammonium acetate (pH 5.8) buffer. Then, 25 m-units of the recombinant neuraminidase was added and the sample was incubated for 18 h at 37
• C. Another aliquot of the enzyme was added, and the sample was again incubated for 18 h at 37 • C. Glycans were then purified using a Sep-Pak C 18 cartridge using the propan-1-ol/5 % acetic acid method before freeze-drying.
Chemical derivatization
vWF N-glycans were explored using a technique adapted from a previously developed strategy published by Yu et al. [25] . Freeze-dried and purified vWF N-glycans were dissolved in approximately 100 μl of the NaOH/DMSO slurry and 100 μl of methyl iodide. The samples were gently mixed and incubated for 3 h at 4
• C. The permethylation was then stopped by the addition of a few drops of ice-cold water, followed by pH neutralization to approximately pH 6.5 using a 5 % acetic acid solution. Glycans were then cleaned-up using a Sep-Pak C 18 cartridge with the acetonitrile/water protocol. The reverse-phase was conditioned successively with methanol, water, acetonitrile and water. The sample was dissolved in 1:1 (v/v) methanol/water and loaded on to the cartridge. Hydrophilic salts and contaminants were washed off by passing 10 ml of water, then 5 ml of a 2.5 % (v/v) acetonitrile solution. Glycans were then sequentially eluted (according to their size and composition) using 5 ml of 10 %, 25%, 50% and 75 % (v/v) aqueous acetonitrile solution. Organic solvent from each fraction was removed on a Savant Speed-Vac and samples were freeze-dried.
Linkage analysis
Permethylated N-glycans were hydrolysed to partially methylated monosaccharides by incubation in 2 M TFA at 121
• C for 2 h. Samples were dried under a stream of nitrogen. Reduction of the monosaccharides and tagging of their C-1 was achieved by incubation for 2 h at room temperature in a 10 mg/ml NaB 2 H 4 (sodium tetradeuteroborate) in 2 M ammonium hydroxide solution. The reaction was terminated by the addition of five drops of acetic acid and samples were dried under a stream of nitrogen. Excess borates were removed by co-evaporation with a 10% (v/v) acetic acid in methanol solution followed by drying under a stream of nitrogen. Samples were acetylated by incubation in acetic anhydride for 1 h at 100
• C and then dried under a stream of nitrogen. The resulting products were extracted with chloroform in the same way as permethylated samples. The chloroform layer was dried down and the PMAAs (partially methylated alditol acetates) were dissolved in hexanes prior to GC-MS analyses, performed on a PerkinElmer Clarus 500 GC-MS machine fitted with an RTX-5MS column (30 m long, 0.25 mm internal diameter, Thames Restek U.K.). The PMAAs were injected at 60
• C then the temperature was increased at a rate of 8
• C/min to a temperature of 300 • C. Data were acquired and processed using GC-MS Turbomass v4.5.0 Instrument Control software.
Affinity chromatography on UEA-I (Ulex europaeus agglutinin I) lectin UEA-I has been reported to bind efficiently and specifically to fucosylated structures and especially to blood group H containing type 2 chain epitopes (Fucα1-2Galβ1-4GlcNAc) [26] . Agarosebound UEA-1 (2 ml) (EY Laboratories) was packed in a 2 ml glass column and equilibrated using 10 column volumes of a buffer containing 10 mM sodium phosphate and 150 mM NaCl (pH 7.4). The flow rate was set up at 0.1 ml/min for the whole experiment. vWF desialylated glycopeptides aliquots (obtained from treatment by neuraminidase, as described above) were dissolved in 100 μl of PBS and loaded on to the column. The column was washed by 10 column volumes and the subsequent unbound fraction was collected. Bound glycopeptides were then eluted using the same buffer containing 500 mM L-fucose. Both bound and unbound fractions were immediately purified using a Sep-Pak C 18 cartridge with the propan-1-ol/5 % acetic acid method to remove the salt and sugar excess prior to LC (liquid chromatography) separation and/or MS analyses.
Nano-LC separation and spotting
vWF tryptic digests were analysed by off-line LC-MALDI-TOF-MS (matrix-assisted laser-desorption ionization-time-offlight MS). Peptides and glycopeptides were separated using an Ultimate 3000 LC system (Dionex), fitted with an analytical Pepmap C 18 nanocapillary column (15 cm length, 75 mm internal diameter; Dionex). The flow rate was set up at 0.3 μl/min. The sample, diluted in 0.1 % TFA, was loaded on to the column. 
MALDI-TOF-MS analyses
Derivatized vWF N-glycans were dissolved in 20 μl of 1:1 (v/v) methanol/water or vWF peptides were dissolved in 50 μl of 0.1 % TFA. Sample (1 μl) was mixed with 1 μl of the matrix [for glycans in positive-ion mode, 10 mg/ml 2,5-dihydroxybenzoic acid in 50:50 (v/v) methanol/water; for glycans in negative-ion mode, 10 mg/ml DABP in 50:50 (v/v) acetonitrile/0.1 % TFA; for peptides, 5 mg/ml in 50:50 (v/v) 0.1 % TFA/acetonitrile]. Then, 1 μl of the subsequent mixture was spotted on to a 100-well sample plate and dried under vacuum. MALDI-TOF-MS analysis was performed using a Voyager DE-STR TM mass spectrometer (Applied Biosystems) in the reflectron mode with delayed extraction. The instrument was calibrated externally using the Calmix 4700 calibration standard, containing desArg1-bradykinin (molecular mass 904. 
MALDI-TOF/TOF-MS/MS (tandem MS) analyses
Sample-matrix mixtures were prepared as described above, spotted on to a MALDI-TOF/TOF sample plate and dried under vacuum. MS/MS data were acquired using a 4800 MALDI TOF/TOF TM mass spectrometer (Applied Biosystems). The collision energy was set to 1 kV and argon was used as the collision gas. The instrument was calibrated using [Glu 1 ]-fibrinopeptide B human (Sigma-Aldrich) as the external calibrant for the MS/MS mode and the 4700 calibration standard, Calmix, was used as the external calibrant for the MS mode. Data were acquired using 4000 Series Explorer Instrument Control Software and were processed using Data Explorer MS processing software.
RESULTS
Human plasma vWF was purified from Haemate P, a commercial plasma concentrate manufactured for patients with haemophilia or VWD (von Willebrand disease), using size-exclusion and affinity-chromatography techniques. The strategy undertaken to achieve vWF glycomics and site-by-site glycosylation analyses is summarized in Figure 1 . For glycomics analyses, vWF was reduced, carboxymethylated and digested with trypsin. N-glycans were released by PNGase F digestion, purified using a reversephase C 18 cartridge then permethylated prior to MALDI-TOF and -TOF/TOF analyses. Glycomics experiments were supplemented by enzymatic treatment (neuraminidase, β-galactosyltransferase and endo-β-galactosidase). For glycoproteomics analyses, vWF tryptic digests were desialylated using sialidase A and, in some experiments, enriched by UEA-I affinity chromatography, prior to analyses using an off-line C 18 nano-LC MALDI-TOF/TOF system.
Data from the permethylated vWF N-glycans MALDI-TOF-MS analysis are shown in Figure 2 and Supplementary Table S1 (at http://www.BiochemJ.org/bj/447/bj4470217add.htm). For glycomics data, all molecular ions are [M + Na] + and panels are normalized to 100 % intensity unless otherwise stated. Structural assignments are based on monosaccharide composition (MALDI-TOF-MS and GC-MS), fragmentation analyses (MS/MS), enzymatic digest sequencing and knowledge of the glycan biosynthetic pathways. Bearing in mind that a single molecular ion is often composed of several isoforms (as exemplified in Figure 3 ), the proposed structures either correspond to the most abundant isoform, or are representative of a group carrying a common structural motif. 
N-glycan fucosylation
A high proportion of molecular ions are consistent with complextype multi-fucosylated N-glycans, suggesting fucosylation of both core and antennae (m/z 2418.2, 3041.5, 4025.9 etc.), in accordance with a previous publication reporting the occurrence of ABH blood group antigens on vWF N-glycans [15] . The presence of fucose residues was confirmed by GC-MS as shown in Table 1 
Presence of lactosamine extensions
Some high-mass molecular ions suggest the presence of LacNAc extensions because the total of LacNAc units is higher than the four needed for a tetra-antennary glycan ( Figure 2D ; m/z 4314.1, 4488.2 and 4675.2). In addition, CID fragmentation of many lower mass molecular ions such as m/z 3054.5 yielded fragment ions characteristic of LacNAc elongations ( Figure 3B ; m/z 1296, 1781 and 2142), highlighting that this feature is also present in bi-and tri-antennary structures. The presence of LacNAc elongations was also assessed by digesting native vWF N-glycans with an endo-β-galactosidase prior to permethylation and MS analyses. The low-mass region of the subsequent MS spectrum (Supplementary Figure S3A at http://www.BiochemJ.org/bj/447/bj4470217add.htm) contains a variety of molecular ions consistent with lactosaminic elongations, with or without ABH blood group epitopes or a sialic acid residue (m/z 722.4, 896.5, 1083.6, 1100.6, 1141.6 and 1171.6). The structure of these elongations was confirmed by MS/MS analysis as shown in Supplementary Figures S3B and S3C.
Presence of both bisecting and terminal GlcNAc residues
A number of glycan compositions determined by MS analysis suggest the presence of HexNAc residues additional to those present in the N-glycan core plus the LacNAc building
Figure 2 MALDI-TOF-MS profile of the permethylated N-linked glycans from vWF
The full-scale spectrum (A) and subsequent magnified portions (B-D; m/z 1500-2500, 2500-3500 and 3500-5000 respectively) show the high complexity of the vWF glycan population. Structural assignments were based on compositions assigned from molecular masses, complemented by MS/MS information and the results of glycosidase digests. As discussed in the text, individual signals often correspond to a number of isomers, but for clarity only the most abundant isoform or one representative of a family carrying a common structural motif is represented. All molecular ions are [M + Na] + and panels are normalized to 100 % intensity. Structural assignments are based on monosaccharide composition, fragmentation analyses and knowledge of the glycan biosynthetic pathways. The sugar symbols are those employed by the Consortium for Functional Glycomics (http://www.functionalglycomics.org).
blocks of the antennae (Figure 2 ; m/z 2315.2, 2663.3, 3211.6 etc.). These extra HexNAcs could theoretically be attributed to GalNAc residues forming the A antigen in the periphery, to Sda epitopes [NeuAcα2,3(GalNAcβ1-4)Galβ1-4GlcNAc], to bisecting GlcNAc residues or to non-galactosylated antennae.
The A antigen was characterized by MS/MS analysis of a number of molecular ions of this subpopulation, as shown in confirms the presence of blood group H epitope. In the lower structure representation, the terminal non-reducing GlcNAc residue could also be a bisecting GlcNAc. (B) Collisional activation of the m/z 3054 parent ion provides evidence for numerous isoforms, as well as the presence of lactosaminic elongations (diagnostic fragment ions at m/z 1296, 1781 and 2142). The three core fucosylated structures that are shown are assigned as the major components based on fragment ion abundances. However, the antenna fragment ion at m/z 660 indicates the presence of other components carrying a fucosylated N-acetyl lactosamine antenna and therefore lacking core fucosylation (not represented). Taking into account different antennae and core fucosylation combinations, at least 12 different isoforms can be attributed to this single molecular ion.
within the population of N-glycan-derived PMAA (retention time 21.43 min; Supplementary Figure S2D ). This residue is characteristic of bisected structures in which the 3,6-substituted β-Man is additionally substituted by the so-called bisecting GlcNAc in a β1-4 linkage. Finally, in order to confirm or exclude the presence of terminal non-bisected GlcNAc residues (nongalactosylated or truncated antennae), native N-glycans were incubated with β 1,4 -galactosyltransferase in the presence of UDPGal. This enzyme catalyses the addition of a galactose residue to exposed GlcNAc residues, but, due to steric hindrance, does not have access to bisecting GlcNAc residues. The resulting MALDI-TOF spectra of vWF permethylated N-glycans before and after incubation are shown in Supplementary Figure S4 a terminal GlcNAc residue in a non-bisected terminal position. Such truncated antennae are particularly uncommon for blood glycoproteins, on which N-glycans tend to be fully processed.
Characterization of sulfated epitopes
A previous report suggested that vWF carries a population of sulfated oligosaccharides [27] . The analysis of sulfated glycans by MS is a difficult task, owing to their general low abundance, the lability of sulfate groups and their poor ionization with standard MS techniques. Nevertheless, an optimized sulfoglycomics methodology has been previously reported by Yu et al. [25] , and its adaptation to the vWF model allowed us to characterize a family of sulfated N-glycans within the oligosaccharide population. The negative-ion mode MALDI-TOF-MS spectrum of the permethylated vWF N-glycans shown in Figure 4 
Glycoproteomics analyses
Following the characterization of the vWF N-glycans, off-line LC-MS/MS glycoproteomics approaches were applied to the study of individual glycosylation sites. In silico tryptic digestion of mature vWF leads to 136 tryptic peptides (molecular mass>500 Da), among which 13 contain a single N-glycosylation consensus sequon (Table 2 ; peptide-mass software; http://www.expasy.org). vWF was reduced, alkylated, trypsinized and digested by neuraminidase (glycoproteomics data) or PNGase F (proteomics data) prior to analysis using a LC Pepmap C 18 nanocapillary column connected to a Probot MALDI spotter and an Applied Biosystems 4800 MALDI-TOF/TOF instrument. Automated interpretation of the proteomics data using the MASCOT search engine (http://www.matrixscience.com) confirmed a high purity level with only trace levels of contaminating peptides. Overall, approximately 60 % of the vWF amino sequence (UniProtKB P04275) was successfully detected and sequenced, among which were ten tryptic peptides possessing a N-glycosylation consensus sequon (Table 2 and Supplementary Figure S6 at http://www.BiochemJ.org/bj/447/bj4470217add.htm). Glycoproteomics analyses were performed manually and led to the observation of various glycosylated forms of each of these ten peptides. With the exception of Asn 1147 , all of these sites appeared to be fully occupied, since their non-glycosylated counterparts were only detected after PNGase F digestion. Comprehensive data are shown for a single N-glycosylation site (Table 2; P4,  I 1509 GEADFNR 1516 ), whereas other individual site glycoproteomics data are summarized in Supplementary Tables S2-S11 ( The importance of localizing the blood group antigens along the vWF amino acid sequence led us to perform affinity chromatography using agarose-bound fucose-specific UEA-I in order to obtain glycopeptide fractions enriched in the H antigen. UEA-I bound and unbound fractions were analysed on the same off-line nano-LC C 18 MALDI-TOF/TOF system. The UEA-Ienrichment step allowed the identification of many glycopeptides containing at least one H antigen, which were masked by more abundant alternative structures in the experiments described above. The MS spectrum shown in Figure 5 (B) was generated by summing the relevant consecutive spectra and therefore shows the overall population of H antigen containing N-glycans found at the Asn 1515 glycosylation site. Mono-to tetra-fucosylated N-glycans were observed, as well as a number of 'extra HexNAc'-and lactosamine-extension-containing species at a relatively high abundance. The presence of an H antigen at Asn 1515 was finally confirmed by CID fragmentation, as shown in the example MS/MS spectrum in Figure 5 (C) (m/z 512.2, 2837.3 and 3348.6).
Unexpectedly, we found that, with the single exception of Asn 1147 , the H antigen is present at all detected vWF N-glycosylation sites. Based on the relative glycopeptide proportions established for all sites (Supplementary Tables S2-S11) , we evaluated the average number of complex-type antennae and occurrence of antennae fucosylation per glycosylation site (Supplementary Table S12 at http://www.BiochemJ.org/bj/ 447/bj4470217add.htm). Interestingly, the highest density of fucosylation was found at Asn 2635 (15.9 % of the antennae being fucosylated), whereas most of the other sites carry N-glycans with approximately 10 % of fucosylated antennae. The three sites Asn 857 , Asn 2290 and Asn 2585 show a much lower degree of antennae fucosylation (1-3 %). In addition, the level of branching was found to be reasonably constant, with 2.2-2.3 antennae per glycan on average, with the exceptions of Asn 857 /Asn 1147 , carrying undersized structures (1.6-2.0 antennae per glycan), and of Asn 1515 /Asn 1574 , showing a greater proportion of bulky N-glycans (2.6 antennae per glycan).
DISCUSSION
The glycomics data in the present study show the great complexity of the vWF N-glycans as a population of approximately 300 distinct structures. Complex-type N-glycans, mainly biantennary, dominate the profile, although traces of high-mannose and truncated structures are also detected (Figure 2 and Table 2 Supplementary Table S1 ). This profile is broadly in agreement with the study performed by Matsui et al. [15] , although these workers only identified the most abundant N-glycans after desialylation, comprising approximately 25 structures. Our analyses highlight a number of epitopes previously unknown on vWF and reveal the nature of low-abundance components that were previously missed. The level of complexity of the vWF N-glycan population is shown as a schematic diagram in Figure 6 (A) and salient structural features are discussed in the next sections. Core fucosylation and capping of the terminal galactose, with either a α2,6 sialic acid or a α1,2 fucose residue, are predominant features. Human vWF N-glycans show a high sialylation status with approximately 50 % of the overall complex-type antennae being capped with an α2,6 neuraminic acid residue, whereas PMAA analyses revealed that approximately 15 % of the vWF N-glycan antennae are capped with an α1,2 fucose residue ( Table 1 ). The presence of Lewis epitopes was ruled out by the absence of 3,4-linked GlcNAc residues in the linkage data and diagnostic fragment ions in MS/MS analyses. ABH antigens were found in similar abundance on all the families of complextype N-glycans, suggesting that α1,2 fucosylation of galactose residues is not a structure-specific process ( Figure 2 and Table 1 ). Evidence for antennae containing both a neuraminic acid and a fucose residue was not found, in keeping with evidence indicating that fucosylation of sialylated antennae is restricted to α2,3 sialylation in mammals [28] . However, 35 % of the total N-glycan compositions identified carry both sialic acid(s) and ABH antigen(s), but on distinct antennae. Finally, in contrast with the vWF O-linked glycans reported recently by our group [29] , no evidence for di-sialic acid motifs has been found on N-glycans. The α2,6 neuraminic acid residues identified in the present paper have been shown to have a protective effect against cleavage by serine and cysteine proteases, but specifically enhance susceptibility to ADAMTS-13 proteolysis [23, 24] . As reported previously [30, 31] , ADAMTS-13 activity is affected by ABH antigens, and it is interesting to note that vWF desialylation abolishes the ABH blood group effect on the ADAMTS-13 proteolysis rate. Terminal α2,6 neuraminic residues are also recognized by the sialic-acid-binding Ig-like lectin family, the Siglecs [30, 31] . Although the individual affinity studies are still in progress, the Consortium for Functional Glycomics data suggest that Siglecs 2, 5, 7, 9 and 10 present a significant affinity for α2,6 NeuAc residues. Interestingly, Lenting et al. [32] recently reported preliminary data suggesting that Siglecs 5, 7 and 9 are able to interact with vWF.
vWF has been reported once to carry sulfated N-glycans at the Asn 1147 and/or Asn 1231 glycosylation sites although, until now, this early observation has not been corroborated with structural evidence [27] . Using a modern MS-based methodology, a pool of approximately ten mono-sulfated N-glycans was firmly identified in the present study (Figure 4) , comprising bi-and tri-antennary structures containing at least one fucose and one NeuAc residue. From our MS/MS data, we conclude that sulfation occurs mainly on the sialylated LacNAc antennae (Supplementary Figure S5) . Antennae sulfation may have important implications, in particular with regard to recognition by specific glycan binding proteins. Human B cells expressing Siglec 2 have also been shown to interact with α2,6 sialylated 6-sulfo-LacNAc epitopes [33] . Although the nature of the recognition remains unclear, vWF is known to interact with P-selectin, and it is believed that this interaction is key to anchoring high-molecular-mass vWF to the surface of stimulated endothelial cells, thus facilitating their cleavage by ADAMTS-13 [34] . Interaction between P-selectin and its major ligand (P-selectin glycoprotein ligand-1) is known to be mediated by both a sialyl Lewis X epitope and an adjacent sulfated tyrosine residue. Although Lewis X is absent on vWF N-glycans, sulfation of an antenna could conceivably, in conjunction with fucosylation of another nearby antenna, constitute a motif recognized by P-selectin.
Our glycoproteomics data showed that N-glycans substituted with blood group H antigen are present on all but one of the observed glycosylation sites, although its abundance is not uniform, as shown in Figure 6(B) . Glycans of the N-terminal domain (Asn 857 and Asn 1147 ) lack significant antennae fucosylation. Asn 2290 and Asn 2585 are rather poorly fucosylated relative to other sites, of which approximately 10 % of the antennae are substituted with a α1,2 fucose (Supplementary Table S12 ). The most heavily fucosylated site is Asn 2635 , on which N-glycans carry the H antigen on approximately 16 % of its antennae which is surprising and important, as this later glycosylation sequon was, until now, reported as not glycosylated. The average number of antennae per glycans at individual sites appears to be reasonably constant, with 2.2-2.3 per glycan at most of the sites, with the exception of Asn 857 and Asn 1147 carrying smaller structures, and of Asn 1515 and Asn 1574 whose N-glycans are somewhat more bulky (an average of 2.6 antennae per glycan). These two glycosylation sites flank the ADAMTS-13 cleavage site, and our data suggest that this region is richer in the H antigen than the rest of the molecule. Whether the H antigen density affects cleavage remains to be established. The trend of structural characteristics observed on individual glycosylation sites of desialylated VWF is summarized in Figure 6 (B) and detailed in Supplementary Tables S2-S11. No satisfactory understanding of the correlation of ABH antigen expression with vWF cleavage by ADAMTS-13 has been provided to date. Possible explanations include steric hindrance affecting ADAMTS-13 cleavage, potential recognition of ABH antigens by ADAMTS-13, or an effect of the ABH status on the overall glycosylation. Previous studies have provided interesting evidence that desialylation of vWF abolishes the ABH blood group effect on the ADAMTS-13 cleavage rate, suggesting a relationship between the blood group status and the level of sialylation [22, 23] . It has also been suggested that blood group O-vWF could be more extensively sialylated than A-and B-vWF. It is conceivable that bulky A and B epitopes on one or more antennae sterically hinder sialic acid addition to other antennae on the same or nearby glycans. To address this issue, lectin purification strategies should be developed in the future to allow the enrichment of sialylated forms of blood-group-substituted glycopeptides.
To our knowledge, no other glycoprotein of this complexity has had its glycome and glycoproteome characterized to the depth achieved in the present study. The present study highlights the ability of modern MS-based techniques to provide highly detailed information concerning the diversity of glycoforms of extremely complex glycoproteins which should prove relevant for understanding their correspondingly complex functions. The well-known association between the ABO blood group and plasma concentration of vWF is well documented, and although most evidence suggests that it is mediated by an effect on clearance, the responsible receptors have not been fully identified. The Ashwell (asialoglycoprotein) receptor appears to make some contribution [35] , but additional receptors remain to be identified and knowing that their ligands must exist among the glycan structures described in the present study should aid their identification. Notably, a recent genome-wide association study identified the CLEC4M lectin locus as a novel determinant of the vWF plasma level [36] . Proteolysis is known to be an important mechanism for regulation of vWF function and may also play a role in clearance. We have already demonstrated that N-linked glycans can modulate the vWF interaction with the regulatory enzyme ADAMTS-13 [37] and that a complex balance between ABO antigen and sialic acid content determines the overall susceptibility of vWF to proteolytic degradation [23] . More recent data have indicated that the vWF interacts with the members of the galectin family via its carbohydrate moieties, and that this has an effect on vWF function [38] . The significance of these interactions and their dependence on specific glycan structures at specific sites in the vWF molecule are not yet elucidated, but will be facilitated by the results of the present study. Finally, vWF interacts with many other molecules, both before and after release from the endothelial cell. These include the numerous contents of the Weibel Palade bodies which are largely co-located by binding to vWF and we anticipate these too will be subject to regulation by the vWF glycans. 
Figure S1 GC chromatogram of the partially methylated alditol acetates derived from VWF N-glycans
The retention time, as well as the nature of the eluted species, is indicated above each peak. The N-glycome of von Willebrand factor Tables S2-S11 (a value <1 is taken as 0.5). The total number of antennae for a given glycopeptide is defined by glycopeptides (proportion×number of antennae), the average number being the total number of antennae divided by 100. The total number of fucosylated antennae is multifucosylated glycopeptides (proportion×number of fucosylated antennae), the occurrence of H antigen being expressed as a percentage as the total number of fucosylated antennae divided by the total number of antennae. 
